NYSEArca - Delayed Quote USD

SPDR S&P Biotech ETF (XBI)

94.01 +0.84 (+0.90%)
At close: November 20 at 4:00 PM EST
93.80 -0.21 (-0.22%)
Pre-Market: 4:15 AM EST
Advanced Chart
Loading Chart for XBI
DELL
  • Previous Close 93.17
  • Open 93.38
  • Bid --
  • Ask --
  • Day's Range 92.40 - 94.17
  • 52 Week Range 71.99 - 105.47
  • Volume 10,522,659
  • Avg. Volume 7,838,241
  • Net Assets 7.24B
  • NAV 93.18
  • PE Ratio (TTM) --
  • Yield 0.15%
  • YTD Daily Total Return 4.49%
  • Beta (5Y Monthly) 0.98
  • Expense Ratio (net) 0.35%

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

SPDR State Street Global Advisors

Fund Family

Health

Fund Category

7.24B

Net Assets

2006-01-31

Inception Date

More about SPDR S&P Biotech ETF

Performance Overview: XBI

View More

Trailing returns as of 11/19/2024. Category is Health.

YTD Return

XBI
4.49%
Category
6.70%
 

1-Year Return

XBI
28.43%
Category
25.19%
 

3-Year Return

XBI
8.53%
Category
2.46%
 
View More

People Also Watch

IBB iShares Biotechnology ETF
134.84
+1.09%
 
XLV The Health Care Select Sector SPDR Fund
142.88
+1.18%
 
XLI The Industrial Select Sector SPDR Fund
138.95
+0.11%
 
XLK The Technology Select Sector SPDR Fund
231.13
-0.09%
 
XLF The Financial Select Sector SPDR Fund
49.54
-0.30%
 
XLY The Consumer Discretionary Select Sector SPDR Fund
214.62
-0.44%
 
XLU The Utilities Select Sector SPDR Fund
80.49
+0.05%
 
XLE The Energy Select Sector SPDR Fund
96.34
+1.01%
 
XLP The Consumer Staples Select Sector SPDR Fund
80.22
-0.51%
 
XLB The Materials Select Sector SPDR Fund
92.44
+0.82%
 
XOP SPDR S&P Oil & Gas Exploration & Production ETF
145.06
+1.64%
 
KRE SPDR S&P Regional Banking ETF
65.16
-0.28%
 
SMH VanEck Semiconductor ETF
242.54
-0.67%
 
XHB SPDR S&P Homebuilders ETF
116.55
+1.00%
 
IWM iShares Russell 2000 ETF
230.93
+0.13%
 
XRT SPDR S&P Retail ETF
77.62
-0.88%
 

Holdings: XBI

View More

Top 10 Holdings (27.09% of Total Assets)

SymbolCompany% Assets
INCY
Incyte Corporation 3.01%
UTHR
United Therapeutics Corporation 2.84%
VKTX
Viking Therapeutics, Inc. 2.80%
GILD
Gilead Sciences, Inc. 2.76%
EXAS
Exact Sciences Corporation 2.71%
ABBV
AbbVie Inc. 2.71%
SRPT
Sarepta Therapeutics, Inc. 2.61%
ALNY
Alnylam Pharmaceuticals, Inc. 2.59%
NBIX
Neurocrine Biosciences, Inc. 2.54%
VRTX
Vertex Pharmaceuticals Incorporated 2.53%

Sector Weightings

SectorXBI
Healthcare   100.00%
Real Estate   0.00%
Consumer Cyclical   0.00%
Basic Materials   0.00%
Consumer Defensive   0.00%
Technology   0.00%
Communication Services   0.00%
Financial Services   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%
View More

Recent News: XBI

View More
Can Equal-Weight ETFs Protect From Extreme Concentration?

Can Equal-Weight ETFs Protect From Extreme Concentration?
etf.com 16 days ago
F/m Guides Emerald Advisers’ ETF Debut

F/m Guides Emerald Advisers’ ETF Debut
etf.com 20 days ago
Gold Just Hit a Record High. It Could Be Headed for $3000 Next.

Gold Just Hit a Record High. It Could Be Headed for $3000 Next.
Barrons.com 2 months ago
Bank of America shares top sector trades for 2024

Bank of America shares top sector trades for 2024
Yahoo Finance Video 11 months ago
View More

Research Reports: XBI

View More

  • Trump’s Nomination of RFK Jr. to Lead HHS a Potential Industry Headwind

    Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.

    Rating
    Price Target
    Morningstar• 3 days ago
     

  • Biopharma Election Impact: Potential Reduced IRA Headwind but Unpredictable Challenges

    Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.

    Rating
    Price Target
    Morningstar• 9 days ago
     

  • Biopharma Election Impact: Potential Reduced IRA Headwind but Unpredictable Challenges

    Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.

    Rating
    Price Target
    Morningstar• 12 days ago
     

  • BUY as company raises earnings guidance

    Biogen is a biotech company that develops, manufactures, and sells therapies for treating neurological and neurodegenerative diseases. The company is the market leader in multiple sclerosis drugs and launched the first approved treatments for spinal muscular atrophy and Alzheimer's disease. The company also sells products that treat plaque psoriasis, non-Hodgkin's lymphoma, lymphocytic leukemia, and rheumatoid arthritis. Current research continues on MS and has expanded to include neuroimmunology, ophthalmology, lupus, and other neuromuscular and movement disorders. Founded in 1978, the company is located in Cambridge, Massachusetts, employs 7,570 people, and is a component of the S&P 500.

    Rating
    Price Target
    Argus• 15 days ago
     
View More

Related Tickers

IHF iShares U.S. Healthcare Providers ETF
53.01
+1.81%
 
XMHQ Invesco S&P MidCap Quality ETF
103.85
+1.56%
 
ESPO VanEck Video Gaming and eSports ETF
82.33
+1.44%
 
PXE Invesco Dynamic Energy Exploration & Production ETF
32.03
+1.40%
 
IEO iShares U.S. Oil & Gas Exploration & Production ETF
100.36
+1.29%
 
FHLC Fidelity MSCI Health Care Index ETF
67.90
+1.27%
 
XLV The Health Care Select Sector SPDR Fund
142.88
+1.18%
 
IYH iShares U.S. Healthcare ETF
60.17
+1.14%
 
RSPG Invesco S&P 500 Equal Weight Energy ETF
85.18
+1.12%
 
RSPM Invesco S&P 500 Equal Weight Materials ETF
35.95
+1.10%
 
VDE Vanguard Energy Index Fund ETF Shares
134.73
+1.07%
 
FENY Fidelity MSCI Energy Index ETF
26.51
+1.07%
 
VHT Vanguard Health Care Index Fund ETF Shares
263.01
+1.06%
 
XLE The Energy Select Sector SPDR Fund
96.34
+1.01%
 
XHB SPDR S&P Homebuilders ETF
116.55
+1.00%
 
XMMO Invesco S&P MidCap Momentum ETF
130.00
+0.98%
 
GRPM Invesco S&P MidCap 400 GARP ETF
120.20
+0.95%
 
NANR SPDR S&P North American Natural Resources ETF
57.44
+0.95%
 
HYEM VanEck Emerging Markets High Yield Bond ETF
19.73
+0.92%
 
QTUM Defiance Quantum ETF
65.91
+0.90%
 
RDVY First Trust Rising Dividend Achievers ETF
62.27
+0.89%
 
FTXN First Trust Nasdaq Oil & Gas ETF
31.82
+0.84%
 
USMF WisdomTree U.S. Multifactor Fund
51.11
+0.83%
 
FXZ First Trust Materials AlphaDEX Fund
63.87
+0.82%
 
XLB The Materials Select Sector SPDR Fund
92.44
+0.82%
 
USMC Principal U.S. Mega-Cap ETF
59.20
+0.82%
 
DSTL Distillate U.S. Fundamental Stability & Value ETF
56.84
+0.80%
 
AADR AdvisorShares Dorsey Wright ADR ETF
67.36
+0.79%
 
BBP Virtus LifeSci Biotech Products ETF
61.87
+0.77%
 
DWLD Davis Select Worldwide ETF
38.14
+0.74%
 
IGHG ProShares Investment Grade—Interest Rate Hedged
78.20
+0.70%
 
PTH Invesco Dorsey Wright Healthcare Momentum ETF
44.98
+0.69%
 
GXG Global X MSCI Colombia ETF
23.52
+0.66%
 
COWZ Pacer US Cash Cows 100 ETF
59.19
+0.66%
 
SLX VanEck Steel ETF
69.91
+0.66%
 
IXC iShares Global Energy ETF
42.58
+0.66%
 
FLQM Franklin U.S. Mid Cap Multifactor Index ETF
56.60
+0.66%
 
XLC The Communication Services Select Sector SPDR ETF Fund
97.34
+0.64%
 
IYM iShares U.S. Basic Materials ETF
144.69
+0.64%
 
FMAT Fidelity MSCI Materials Index ETF
52.96
+0.63%
 
PSCC Invesco S&P SmallCap Consumer Staples ETF
38.57
+0.62%
 
PPA Invesco Aerospace & Defense ETF
118.49
+0.61%
 
IJH iShares Core S&P Mid-Cap ETF
64.71
+0.61%
 
PEXL Pacer US Export Leaders ETF
49.14
+0.60%
 
IVOO Vanguard S&P Mid-Cap 400 Index Fund ETF Shares
109.62
+0.60%
 
IMCG iShares Morningstar Mid-Cap Growth ETF
77.85
+0.59%
 
IAU iShares Gold Trust
50.03
+0.58%
 
VPC Virtus Private Credit ETF
22.50
+0.58%
 
OUSM ALPS O'Shares U.S. Small-Cap Quality Dividend ETF Shares
45.38
+0.58%
 
GLD SPDR Gold Shares
244.62
+0.56%
 
IYK iShares US Consumer Staples ETF
68.75
+0.56%
 
VAW Vanguard Materials Index Fund ETF Shares
206.55
+0.55%
 
PKW Invesco BuyBack Achievers ETF
120.83
+0.53%
 
FILL iShares MSCI Global Energy Producers ETF
25.38
+0.52%
 
VB Vanguard Small-Cap Index Fund ETF Shares
249.78
+0.52%
 
CHIQ Global X MSCI China Consumer Discretionary ETF
19.86
+0.51%
 
ONEO SPDR Russell 1000 Momentum Focus ETF
123.62
+0.50%
 
IWP iShares Russell Mid-Cap Growth ETF
130.34
+0.49%
 
FCOM Fidelity MSCI Communication Services Index ETF
58.26
+0.48%
 
SYLD Cambria Shareholder Yield ETF
72.91
+0.48%
 
CWB SPDR Bloomberg Convertible Securities ETF
80.27
+0.48%
 
SDVY First Trust SMID Cap Rising Dividend Achievers ETF
38.23
+0.47%
 
WTV WisdomTree U.S. Value Fund
86.47
+0.47%
 
SMLF iShares U.S. Small-Cap Equity Factor ETF
70.70
+0.47%
 
SPGP Invesco S&P 500 GARP ETF
109.16
+0.45%
 
QGRO American Century U.S. Quality Growth ETF
99.94
+0.44%
 
MOAT VanEck Morningstar Wide Moat ETF
95.35
+0.44%
 
IMCV iShares Morningstar Mid-Cap Value ETF
78.76
+0.43%
 
FAD First Trust Multi Cap Growth AlphaDEX Fund
144.50
+0.42%
 
ROUS Hartford Multifactor US Equity ETF
52.78
+0.42%
 
RWK Invesco S&P MidCap 400 Revenue ETF
120.02
+0.42%
 
SMIN iShares MSCI India Small-Cap ETF
80.30
+0.41%
 
BLOK Amplify Transformational Data Sharing ETF
49.10
+0.41%
 
RWL Invesco S&P 500 Revenue ETF
101.42
+0.41%
 
DON WisdomTree U.S. MidCap Dividend Fund
53.43
+0.39%
 
ECH iShares MSCI Chile ETF
25.51
+0.39%
 
JPUS JPMorgan Diversified Return U.S. Equity ETF
120.09
+0.39%
 
VOE Vanguard Mid-Cap Value Index Fund ETF Shares
170.78
+0.39%
 
FDL First Trust Morningstar Dividend Leaders Index Fund
42.33
+0.38%
 
BCD abrdn Bloomberg All Commodity Longer Dated Strategy K-1 Free ETF
32.28
+0.37%
 
IJJ iShares S&P Mid-Cap 400 Value ETF
129.25
+0.37%
 
AUSF Global X Adaptive U.S. Factor ETF
43.46
+0.37%
 
KIE SPDR S&P Insurance ETF
59.49
+0.34%
 
DIA SPDR Dow Jones Industrial Average ETF Trust
434.29
+0.34%
 
KBWP Invesco KBW Property & Casualty Insurance ETF
121.24
+0.32%
 
WBIL WBI BullBear Quality 3000 ETF
36.15
+0.32%
 
VBR Vanguard Small-Cap Value Index Fund ETF Shares
207.74
+0.32%
 
FIW First Trust Water ETF
107.19
+0.32%
 
IPKW Invesco International BuyBack Achievers ETF
41.08
+0.32%
 
EWX SPDR S&P Emerging Markets Small Cap ETF
60.24
+0.32%
 
RDIV Invesco S&P Ultra Dividend Revenue ETF
51.11
+0.31%
 
JVAL JPMorgan U.S. Value Factor ETF
44.21
+0.31%
 
RAAX VanEck Inflation Allocation ETF
29.85
+0.31%
 
ETHO Amplify Etho Climate Leadership U.S. ETF
61.26
+0.29%
 
DXJS WisdomTree Japan Hedged SmallCap Equity Fund
34.34
+0.29%
 
PHO Invesco Water Resources ETF
69.49
+0.29%
 
DINT Davis Select International ETF
23.26
+0.28%
 
BOUT Innovator IBD Breakout Opportunities ETF
39.16
+0.28%
 
VLU SPDR S&P 1500 Value Tilt ETF
190.46
+0.28%
 
IVOV Vanguard S&P Mid-Cap 400 Value Index Fund ETF Shares
100.06
+0.28%